All Posts

The 2020 Disruptive Dozen

June 1, 2020

TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies…

Read More

Massachusetts Eye and Ear and Massachusetts General Hospital Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID

May 6, 2020

Massachusetts Eye and Ear and Massachusetts General Hospital (MGH) today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The…

Read More

Realizing the Promise of AI in the Clinic

March 6, 2020

The gap between the development of AI and its use and integration in the clinic is closing, as technology, sophisticated algorithms, data sets, and computational capacity are now directly supporting both clinicians and patient care in…

Read More

How Does My Idea Fit Into a Commercial Landscape?

March 4, 2020

Medical research can be an electrifying experience as novel ideas are turned into life-altering solutions. On the other hand, research can also be incredibly frustrating, especially when your work has reached a desired result, yet, you’re not certain…

Read More
tayabba hasan, phd

From the Lab to the Clinic: Hasan Ready to Translate Her Photodynamic Research Into Patient Care

February 19, 2020

After nearly four decades of developing light-based technologies for treating disease at Massachusetts General Hospital (MGH), Tayyaba Hasan, PhD is excited about the potential to turn her discoveries into new treatments for patients. “We’re at a…

Read More

A Q&A with Roger Kitterman

December 10, 2019

How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF.  TIF will allow us to invest in technologies at an earlier stage within our system and drive…

Read More

New Imaging Tools Could Reduce the Deadly Toll of Thrombus and Fibrosis

December 10, 2019

Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars in healthcare costs each year. Thrombus—the formation of blot clots—is the most…

Read More

Acquisitions and Successful Financing Add to the Success of the Partners Innovation Fund

December 10, 2019

The Partners Innovation Fund (PIF) continues to add to their success in moving therapeutic strategies developed within the Partners HealthCare System (PHS) further down the development pipeline. Several recent deals and series A financing rounds support…

Read More

Bayer Partners with Brigham Health and Mass General to Accelerate New Treatments for Lung Disease

December 10, 2019

Approximately 65 million people suffer from chronic obstructive pulmonary disease (COPD) worldwide,  and three million people die from it each year. It is the third leading cause of disease-related death in the U.S. and a significant…

Read More

Partners HealthCare Creates New Investment Funds to Accelerate Innovation in Medicine

October 21, 2019

$80M Investment to Speed Discovery from Lab to Patient, Fuel Life Sciences Economy Partners HealthCare has announced the creation of two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences,…

Read More

AI Insights: Cardiovascular Care

October 10, 2019

Cardiovascular diseases remain the leading cause of death worldwide and rising expense, making this area ripe for AI-enabled innovations. This AI Update includes discussions from the 2019 World Medical Innovation Forum, an interview from Licensing Manager…

Read More

Bayer, Brigham and Women’s Hospital, Massachusetts General Hospital open joint lab for research of new treatments for chronic lung

September 25, 2019

Bayer and Partners HealthCare’s founding members Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases. The joint…

Read More

B-BIC Helps Investigators Build Business Skills

September 3, 2019

If you’re a Partners investigator who is interested in moving a discovery from your lab into the clinic, the programs offered by the Boston Biomedical Innovation Center (B-BIC) can help to prepare you for the professional…

Read More

Improving Diagnostic Imaging

September 3, 2019

If you’ve ever tried to take a picture of a squirming baby, you know how tough it can be to get a quality image of something that’s always on the move. A similar challenge can be…

Read More

Partners Collaboration Supports Successful IPO for Health Catalyst

September 3, 2019

In many areas of disease, detection and early intervention are key tools in lessening the burden of disease and improving health outcomes for patients. The same approach is proving true at the population health level where…

Read More

Innovation Fellows Gain Valuable Industry Connections

September 3, 2019

The Partners Innovation Fellows Program provides up-and-coming faculty/staff physicians and investigators from Partners   with an opportunity to work with an industry partner on an onsite, team-based Fellow’s Project to get hands-on experience and mentorship in the…

Read More

Becker’s Health Highlights Partners Innovation Platforms

September 3, 2019

To read the full interview, click here.

Read More

Drug Delivery Directly to the Tumor

September 3, 2019

Historically, scientists have thought of cancer cells as a clone army—since they are all genetically identical, they are universally bad actors. “What we’ve learned since then is that they are more like special forces,” says David…

Read More